Transcripts

Phathom Pharmaceuticals (PHAT) earnings call transcripts

Earnings call transcripts for Phathom Pharmaceuticals, Inc., with a summary, the guidance given, and what analysts pressed on.

FreeSee Phathom Pharmaceuticals' financials in GloomOpen in browser →
  • Q3 2026 earnings call

    Management framed the quarter as evidence that access initiatives are beginning to support growth while the company sustains profitability and funds GI expansion plans.

    Oct 29, 2026Positive0.68
  • Q2 2026 earnings call

    Management framed the quarter as proof of its GI-first pivot, while identifying prescription-access friction as the main near-term constraint on broader growth.

    Jul 30, 2026Positive0.55